echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > Lancet Diabetes Endo: The impact of hypoglycemic drug prescriptions on the risk of death from new coronary pneumonia in diabetic patients

    Lancet Diabetes Endo: The impact of hypoglycemic drug prescriptions on the risk of death from new coronary pneumonia in diabetic patients

    • Last Update: 2021-04-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Among the risk factors for death from new coronary pneumonia , type II diabetes is one of the more important and common factors.


    Coronavirus disease

    Recently, researchers investigated the impact of different hypoglycemic prescriptions for patients with type II diabetes on the risk of death from new coronary pneumonia.


    Recently, researchers investigated the impact of different hypoglycemic prescriptions for patients with type II diabetes on the risk of death from new coronary pneumonia.


    This study was carried out in the United Kingdom and is a national observational cohort study of diabetic patients.


    This study contains a total of 2,851,465 type 2 diabetes patients data.


    Infection receiving metformin risk of death in patients was 0.


    Studies have found that some hypoglycemic drugs can reduce the risk of death in diabetic patients after contracting new coronary pneumonia, but the risk difference is small, and the risk of confusion cannot be ruled out.


    Some hypoglycemic drugs can reduce the risk of death in diabetic patients after contracting new coronary pneumonia, but the risk difference is small, and the risk of confusion cannot be ruled out.


    Original source:

    Prof Kamlesh Khunti et al.


    Prescription of glucose-lowering therapies and risk of COVID-19 Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.